Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$11.58 - $15.46 $125,110 - $167,029
-10,804 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$10.43 - $12.81 $866,691 - $1.06 Million
-83,096 Reduced 88.49%
10,804 $125,000
Q1 2021

May 14, 2021

SELL
$10.24 - $14.6 $89,456 - $127,545
-8,736 Reduced 8.51%
93,900 $1.05 Million
Q4 2020

Feb 02, 2021

BUY
$9.67 - $12.05 $65,137 - $81,168
6,736 Added 7.02%
102,636 $1.11 Million
Q3 2020

Nov 05, 2020

BUY
$8.73 - $15.15 $837,207 - $1.45 Million
95,900 New
95,900 $1.02 Million

Others Institutions Holding IMTX

About Immatics N.V.


  • Ticker IMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,227,000
  • Market Cap $623M
  • Description
  • Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...
More about IMTX
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.